"TRAcheostomy With Single Use Bronchoscopes vs. Conventional Bronchoscopes"
- Conditions
- Respiratory Insufficiency
- Interventions
- Device: Conventional Multi Use Bronchoscopy for PDTDevice: Single Use Bronchoscopy for PDT
- Registration Number
- NCT03952247
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Brief Summary
Optical guidance for percutaneous tracheostomy in intensive care is usually performed by conventional multi use bronchoscopy. Recently a single use bronchoscope has been introduced that allows for endotracheal visualization.
For feasibility evaluation, 23 patients in intensive care receive percutaneous tracheostomy with optical guidance by the Ambu® aScopeTM 4 bronchoscope and 23 patients in intensive care receive percutaneous tracheostomy with a conventional bronchoscope (Olympus BF Type P60). The primary end point is the visualization through the single use bronchoscope of endotracheal landmark structures for tracheostomy and visualization of the needle insertion (according to score, see detailed description).
- Detailed Description
Background Long-term ventilated critically ill patients often receive a tracheostomy to facilitate weaning from the ventilator and for prevention of secondary complications by the endotracheal tube. Besides surgical tracheostomy in which a muco-cutaneous fistula is prepared between trachea and outer skin, percutaneous tracheostomy (PDT) has been introduced, in which a cannula is being inserted into the trachea. After introduction of a guidewire, the trachea is then dilated. This intervention should be led by optical guidance, i. e. to verify the correct point of tracheal cannulation between the 2nd and 3rd tracheal cartilage and to minimize the risk for accidental injury to the membranous part of the trachea. Usually, optical guidance is performed by conventional multi use bronchoscopy. During bronchoscopy in ventilated patients, a drop in minute ventilation or an increase of carbon dioxide partial pressure with a consecutive respiratory acidosis may occur. Recently, a single use bronchoscope has been introduced that permits a continuous visualisation of the trachea on a monitor connected to the camera (Ambu® aScopeTM 4, Ambu, Ballerup, Denmark) . In this study, it is being evaluated whether the optical guidance during PDT can be performed by the Ambu® aScope 4. The advantage of a single use bronchoscope for percutaneous dilatative tracheostomy in comparison to a conventional reuseable bronchoscope is that there is no need for repair or decontamination after use.
Methods:
Design of Study/ No. of Patients:
Randomized, prospective study/ 46 patients With a sample size of 46 (randomized 1:1 in 2 groups of 23 each) a difference of 35% on a visualization score \[6\] may be seen with an α-error of 0,05 and a β-error of 1-0,8.
Procedures:
* screening for study inclusion according to inclusion and exclusion criteria.
* Percutaneous tracheostomy with Ciaglia Blue Rhino technique
* Visualization of PDT via a conventional multi use bronchoscope vs the aScopeTM 4 single use bronchoscope.
study inclusion: All patients being treated in the Dept. of Intensive Care Medicine receiving percutaneous tracheostomy due to long term ventilation are screened according to inclusion and exclusion criteria.
Details of study-procedures:
Bronchoscopy:
The bronchoscopy for percutaneous tracheostomy is done according to the standard operating procedure of the Dept. for Intensive Care Medicine. Furthermore, during this study the bronchoscopy is done by a physician with an experience of more than 200 bronchoscopies.
Percutaneous Tracheostomy:
The tracheostomy is performed according to the Ciaglia Blue Rhino method(Ciaglia Blue Rhino® G2, Cook Medical, Bloomington, IN, USA). After skin incision and an optional blunt dissection of the subcutaneous tissue, the trachea is cannulated between the 2nd and 3rd tracheal cartilage.
Visualization is provided by a conventional multi use bronchoscope or by a single use bronchoscope. Should visualization be insufficient by a single use bronchoscope backup is provided by a conventional multi use bronchoscope.
The tracheostomy is performed by an experienced fellow or attending physician. rating of visualization of tracheal structures and ventilation during percutaneous dilatational tracheostomy:
Rating (each item 1 to 4 points)
A) Identification of: thyroid cartilage, cricoid cartilage, 1st-3rd tracheal cartilage:
1 Reliable identification; 2 Only cricoid cartilage and tracheal cartilages; 3 Only tracheal cartilages; 4 No vision on tracheal structures
B) Visualization of tracheal circumference:
1 Complete; 2 circumference 1/3 to 2/3 of circumference; 3 Only small parts of trachea; 4 No vision on tracheal structures
C) Monitoring puncture: midline + level below 1st or 2nd tracheal cartilage:
1 Reliable identification; 2 Midline sure Level uncertain, but below the 1st tracheal cartilage; 3 Level of puncture uncertain; 4 No vision on tracheal structures
D) Monitoring dilatation Anterior wall and Pars membranacea (P.m.) visible:
1 Reliable identification; 2 P.m. only; 3 Only small parts of trachea visible, no control of P.m.; 4 No vision on tracheal structures
E) Quality of Ventilation Before puncture and worst ventilation during PDT, respectively:
1 Minute ventilation (MV) as before starting tracheotomy; 2 MV \< 2 L/min or oxygen saturation (SO2) 80-90% (\>2minutes); 3 MV \< 0,5l /min or SO2 70 - 79% (\> 2 minutes); 4 MV = 0 or SO2 \< 70% (\> 2 minutes)
F) Quality of the suction channel:
1 Uncomplicated suction of secretion; 2 suction only under flush; 3 suction only possible after multiple removing and flushing of the bronchoscope.; 4 suction not possible.
Consent: all patients or their legal surrogate give written informed consent.
Data protection: Data are anonymized.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 46
- Patients receiving percutaneous tracheotomy in the Dept. of Intensive Care Medicine.
- Age ≥ 18 years
- Informed consent
- Age < 18 years
- No consent
- Direct laryngoscopy according to Cormack-Lehane ≥ 3
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Conventional Multi Use Bronchoscopy Conventional Multi Use Bronchoscopy for PDT optical guidance of percutaneous tracheotomy is done by conventional multi use bronchoscopy Single Use Bronchoscopy Single Use Bronchoscopy for PDT optical guidance of percutaneous tracheotomy is done by single use bronchoscopy
- Primary Outcome Measures
Name Time Method Visualisation during tracheotomy visualisation through the single use bronchoscope of endotracheal landmark structures for tracheotomy and visualization of the needle insertion (according to score) Scale Name: Rating A) Identification of: thyroid cartilage, cricoid cartilage, 1st-3rd tracheal cartilage 1 Reliable identification; 2 Only cricoid cartilage and tracheal cartilages; 3 Only tracheal cartilages; 4 No vision on tracheal structures B) Visualization of tracheal circumference 1 Complete; 2 circumference 1/3 to 2/3 of circumference; 3 Only small parts of trachea; 4 No vision on tracheal structures C) Monitoring puncture: midline + level below 1st or 2nd tracheal cartilage
1 Reliable identification; 2 Midline sure Level uncertain, but below the 1st tracheal cartilage; 3 Level of puncture uncertain; 4 No vision on tracheal structures D) Monitoring dilatation Anterior wall and Pars membranacea (P.m.) visible; 1 Reliable identification; 2 P.m. only; 3 Only small parts of trachea visible, no control of P.
- Secondary Outcome Measures
Name Time Method Poor control during tracheotomy Poor control of the single use bronchoscope:
Intubation of only one bronchial Segment not possible; Intubation of more than one bronchial Segment not possible.pH three time points: baseline value (before sterile drapes are applied), 0 min before skin incision, and 0 min after insertion of tracheal cannula change in pH-values
Measurement during following time Points:
1. Measurements of pH values before sterile drapes are applied; preintervention
2. Measurement of Changes in pH values before Skin incision and during identification of landmark structures
3. Measurement of pH values after Insertion of the tracheal canulaadverse events up to 1 week any adverse events that are likely associated with tracheostomy
paO2 three time points: baseline value (before sterile drapes are applied), 0 min before skin incision, and 0 min after insertion of tracheal cannula Change in paO2 values
Measurement during following time Points:
1. Measurements of paO2 values before sterile drapes are applied; preintervention
2. Measurement of Changes in paO2 values before Skin incision and during identification of landmark structures
3. Measurement of paO2 values after Insertion of the tracheal canulapaCO2 three time points: baseline value (before sterile drapes are applied), 0 min before skin incision, and 0 min after insertion of tracheal cannula Change in paCO2 values
Measurement during following time Points:
1. Measurements of paCO2 values before sterile drapes are applied; preintervention
2. Measurement of Changes in paCO2 values before Skin incision and during identification of landmark structures
3. Measurement of paCO2 values after Insertion of the tracheal canulaetCO2 three time points: baseline value (before sterile drapes are applied), 0 min before skin incision, and 0 min after insertion of tracheal cannula Change in etCO2 values
Measurement during following time Points:
1. Measurements of etCO2 values before sterile drapes are applied; preintervention
2. Measurement of Changes in etCO2 values before Skin incision and during identification of landmark structures
3. Measurement of etCO2 values after Insertion of the tracheal canulaMinute ventilation two time points: 1. during identification of landmark structures before puncture of trachea, 2. during puncture, dilatation and tracheotomy minute ventilation (according to score)
Scale Name: Quality of Ventilation
1 Minute ventilation (MV) as before starting tracheotomy; 2 MV \< 2 L/min or oxygen saturation (SO2) 80-90% (\>2minutes); 3 MV \< 0,5l /min or SO2 70 - 79% (\> 2 minutes); 4 MV = 0 or SO2 \< 70% (\> 2 minutes)Poor visualisation during tracheotomy Poor visualisation with single use bronchoscopy Poor identification thyroid cartilage, cricoid cartilage, 1st-3rd tracheal cartilage : Only identification of tracheal cartilages; No vision possible on tracheal structures Poor visualization of tracheal circumference: Only visualisation of small parts of trachea; No vision on tracheal structures
Poor monitoring of puncture: midline + level below 1st or 2nd tracheal cartilage
: Level of puncture uncertain; No vision on tracheal structures Poor Monitoring of Dilatation: Only small parts of trachea visible, no control of P.m.; No vision on tracheal structuresPeak airway pressure three time points: baseline value (before sterile drapes are applied), 0 min before skin incision, and 0 min after insertion of tracheal cannula changes in peak airway pressure of ventilator if volume controlled mode is used
Measurement during following time Points:
1. Measurements of Peak airway pressure before sterile drapes are applied; preintervention
2. Measurement of Changes in Peak airway pressure before Skin incision and during identification of landmark structures
3. Measure of Peak airway pressure after Insertion of the tracheal canulaDuration of intervention during tracheotomy (skin incision till insertion of tracheal cannula) Duration of Intervention
Measurement of Duration of Intervention from Skin incision till Insertion of tracheal cannula (measured in minutes)
Trial Locations
- Locations (1)
Universitätsklinikum Hamburg-Eppendorf
🇩🇪Hamburg, HH, Germany